NantHealth Inc is a healthcare company that employs precision medicine and technology to give physicians, payers, and patients more information. The company develops software and hardware to collect, indexes, analyze and interpret molecular, financial, clinical, and operational data points to improve decision making. The company provides cancer care solutions, provide solutions, and payer solutions.
On Friday, the stock closed after a 98% run up from the stocks opening price. Heavy volume drove the stock price which traded 2.98 million shares Friday after having an average 30 day trading volume of just 3771 (according to LDMicro). The stock, Nasdaq: NH, closed at $5.70 and has a 52 week range of between $1.57-$17.25
In 2016, Dr. Patrick Soon-Shiong’s – the founder and CEO of NantHealth Inc., closed its initial public offering of 6.5 million shares, which were sold at $14 a share.
